New 2009 Impact Factors Soar for Newest Cell Press Journals
Impressive increases for Cell Stem Cell and Cell Host and Microbe rankings; Cell remains top journal in its field
Cambridge, Mass., USA, 21 June, 2010 – In the year since their 2008 preliminary ranking, Cell Press journals Cell Stem Cell and Cell Host and Microbe saw their Impact Factors surge, according to new data released in the 2009 Journal Citation Reports© published by ThomsonReuters.
In the report released June 17, Cell Stem Cell’s rating rose to 23.563 - a growth of 40% from the journal’s previous score. Cell Host and Microbe ranks 13.021 - boasting an increase of 75% from the journal’s 2008 Impact Factor.
Cell, the flagship journal of Cell Press, an imprint of Elsevier, remains the number one research journal in the Cell Biology and Biochemistry & Molecular Biology subject categories, with an Impact Factor of 31.152.
“We are thrilled to see our two youngest journals spur such incredible growth in 2009,” said Emilie Marcus, editor-in-chief of Cell Press. “We are proud of the work all of our publications contribute to the scientific community, and grateful to our authors and reviewers who help make this possible.”
The ranking also reveals that Cancer Cell continues to grow with a 2009 rating of 25.288. Molecular Cell saw an impressive 13% increase to 14.608, and The American Journal of Human Genetics, a Society journal within the Cell Press publishing portfolio, saw its Impact Factor jump 21% in 2009 to 12.303.
The 2009 Journal Citation Reports© ranks the Cell Press journals’ Impact Factors as follows: Cancer Cell (25.288), Cell (31.152), Immunity (20.589), Current Biology (10.992), Structure (5.904), Molecular Cell (14.608), Cell Metabolism (17.35), Cell Stem Cell (23.563), Cell Host and Microbe (13.021), Chemistry and Biology (6.523), Neuron (13.26), Developmental Cell (13.363), Trends in Biochemical Sciences (11.572), Trends in Cognitive Sciences (11.664), Trends in Genetics (8.689), Trends in Microbiology (6.894), Trends in Molecular Medicine (11.049), Trends in Neuroscience (12.974), Trends in Plant Science (9.883), Trends in Biotechnology (6.909), Trends in Cell Biology (12.115), Trends in Ecology and Evolution (11.564), Trends in Endocrinology and Metabolism (6.562), Trends in Immunology (8.768), Trends in Parasitology (4.298), Trends in Pharmacological Sciences (9.064), and Society Journals, American Journal of Human Genetics (12.303), and Biophysical Journal (4.39).
The Impact Factor is a measure of the frequency with which the average article in a journal has been cited in a particular year. The Impact Factor helps to evaluate a journal's relative importance, especially when compared with others in the same field.
For more information about Cell, Cell Press, and its group of scientific journals, please log on to http://www.cell.com.
# # #
About Cell Press
Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the scientific community it serves. Cell Press primary research journals include the flagship journal Cell, as well as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry & Biology, Cell Metabolism, Cell Host & Microbe, Cell Stem Cell, and, new to Cell Press, Biophysical Journal, and The American Journal of Human Genetics. Cell Press also publishes the Trends family of reviews journals, including Trends in Cell Biology, Trends in Neurosciences, and Trends in Cognitive Sciences. (www.cell.com).
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).